無料プレビュー

Haleon plc (HLN) · New York Stock Exchange

プロフィール

Haleon plc is a significant global entity in the consumer healthcare sector, engaging in the entire process from scientific research and development to the production and worldwide distribution of various wellness goods. The company's reach extends across North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific region. Its diverse product portfolio encompasses therapeutic solutions for oral care, pain management, respiratory well-being, and digestive health, alongside a comprehensive range of vitamins, minerals, and other dietary supplements. Noteworthy brands within

主要指標

株価: $9.26 (+2.66%)
時価総額: 408億ドル
PER（今期予想）: 16.6
PBR: 1.9
配当利回り: 2.14%
52週レンジ: $8.65 – $11.28
業種: Healthcare / Drug Manufacturers - Specialty & Generic
上場: New York Stock Exchange
構成銘柄: —

比較会社: GSK GSK plc、CL Colgate-Palmolive Company、TAK Takeda Pharmaceutical Company Limited、TEVA Teva Pharmaceutical Industries Limited、KVUE Kenvue Inc.、ZTS Zoetis Inc.、CHD Church & Dwight Co., Inc.、VTRS Viatris Inc.

長期トレンド・直近動向・強気／弱気シナリオ・業績10年・バリュエーション・テクニカル・株主・役員・深掘り分析は会員向けです。

7日間無料で全文を読むログイン

次回決算: 2027-03-04 · 更新: 2026-10-09